Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty

Trends in Molecular Medicine

Volumn 18, Issue 3, 2012, Pages 145-155

  Gill, Harinderjit S ^a   Grammatopoulos, George ^a   Adshead, Stephen ^b   Tsialogiannis, Evagellos ^b   Tsiridis, Eleftherios ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; COBALT; NANOPARTICLE;

CYTOTOXICITY; GENOTOXICITY; HIP ARTHROPLASTY; HUMAN; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; METAL IMPLANTATION; METAL ON METAL HIP ARTHROPLASTY; PSEUDOTUMOR; REVIEW; TOTAL HIP PROSTHESIS;

ANIMALS; ARTHROPLASTY, REPLACEMENT, HIP; CHROMIUM ALLOYS; HIP PROSTHESIS; HUMANS; IMMUNE SYSTEM; NANOPARTICLES;

EID: 84858075849     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.12.002     Document Type: Review

References (85)

1. Meier, B. and Roberts, J. (2011) Hip implant complaints surge, even as the dangers are studied. The New York Times 23 August, p. A1.
2. Meier, B. (2011) In medicine, new isn't always improved. The New York Times 26 June, p. BU1.
3. Learmonth I.D., et al. The operation of the century: total hip replacement. Lancet 2007, 370:1508-1519.
4. Iorio R., et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J. Bone Joint Surg. Am. 2008, 90:1598-1605.
5. Garellick, G. et al. (2008) Swedish Hip Arthroplasty Register, Annual Report 2008, Department of Orthopaedics, Sahlgrenska University Hospital.
6. Kadoya Y., et al. Wear and osteolysis in total joint replacements. Acta Orthop. Scand. Suppl. 1998, 278:1-16.
7. Streicher R.M. Hip Resurfacing - A Superior Articulation Concept? 2006, Steinkopff.
8. Weber B.G. Experience with the Metasul total hip bearing system. Clin. Orthop. Relat. Res. 1996, S69-S77.
9. Sieber H.P., et al. Analysis of 118 second-generation metal-on-metal retrieved hip implants. J. Bone Joint Surg. Br. 1999, 81:46-50.
10. Anissian H.L., et al. Metal-on-metal bearing in hip prosthesis generates 100-fold less wear debris than metal-on-polyethylene. Acta Orthop. Scand. 1999, 70:578-582.
11. Daniel J., et al. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. J. Bone Joint. Surg. Br. 2004, 86:177-184.
12. Kurtz S.M., et al. International survey of primary and revision total hip replacement. Trans. Annu. Meet. Orthop. Res. Soc. 2010, 35:0365.
13. Pandit H., et al. Pseudotumours associated with metal-on-metal hip resurfacings. J. Bone Joint Surg. Br. 2008, 90:847-851.
14. Willert H.G., et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J. Bone Joint Surg. Am. 2005, 87:28-36.
15. De Haan R., et al. Revision of metal-on-metal resurfacing arthroplasty of the hip: the influence of malpositioning of the components. J. Bone Joint Surg. Br. 2008, 90:1158-1163.
16. Langton D.J., et al. Adverse reaction to metal debris following hip resurfacing: the influence of component type, orientation and volumetric wear. J. Bone Joint Surg. Br. 2011, 93:164-171.
17. De Smet K., et al. Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J. Bone Joint Surg. Am. 2008, 90(Suppl. 4):202-208.
18. Hart A.J., et al. Sensitivity and specificity of blood cobalt and chromium metal ions for predicting failure of metal-on-metal hip replacement. J. Bone Joint Surg. Br. 2011, 93:1308-1313.
19. Kwon Y.M., et al. Analysis of wear of retrieved metal-on-metal hip resurfacing implants revised due to pseudotumours. J. Bone Joint Surg. Br. 2010, 92:356-361.
20. Medicines and Healthcare Products Regulatory Agency Medical Device Alert. All Metal-on-Metal (MoM) Hip Replacements 2010, MHRA.
21. Sechriest V.F., et al. Activity level in young patients with primary total hip arthroplasty: a 5-year minimum follow-up. J. Arthroplasty 2007, 22:39-47.
22. Doorn P.F., et al. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J. Biomed. Mater. Res. 1998, 42:103-111.
23. Campbell P., et al. The John Charnley Award: a study of implant failure in metal-on-metal surface arthroplasties. Clin. Orthop. Relat. Res. 2006, 453:35-46.
24. Mellon S.J., et al. The effect of motion patterns on edge-loading of metal-on-metal hip resurfacing. Med. Eng. Phys. 2011, 33:1212-1220.
25. Catelas I., Wimmer M.A. New insights into wear and biological effects of metal-on-metal bearings. J. Bone Joint Surg. Am. 2011, 93(Suppl. 2):76-83.
26. Pourzal R., et al. Characterization of wear particles generated from CoCrMo alloy under sliding wear conditions. Wear 2011, 271:1658-1666.
27. Langton D.J., et al. Accelerating failure rate of the ASR total hip replacement. J. Bone Joint Surg. Br. 2011, 93:1011-1016.
28. Donell S.T., et al. Early failure of the Ultima metal-on-metal total hip replacement in the presence of normal plain radiographs. J. Bone Joint Surg. Br. 2010, 92:1501-1508.
29. Clark C.R. A potential concern in total joint arthroplasty: systemic dissemination of wear debris. J. Bone Joint Surg. Am. 2000, 82:455-456.
30. Barceloux D.G. Chromium. J. Toxicol. Clin. Toxicol. 1999, 37:173-194.
31. Merritt K., Brown S.A. Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J. Biomed. Mater. Res. 1995, 29:627-633.
32. Hart A.J., et al. The chemical form of metallic debris in tissues surrounding metal-on-metal hips with unexplained failure. Acta Biomater. 2010, 6:4439-4446.
33. Learmonth I.D., et al. Clinical experience with metal-on-metal total joint replacements: indications and results. Proc. Inst. Mech. Eng. H 2005, 220:229-237.
34. Urban R.M., et al. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J. Bone Joint Surg. Am. 2000, 82:457-476.
35. Smith H.I.C., Carson B.L. Cobalt. An Appraisal of Environmental Exposure (Trace Metals in the Environment) 1981, vol. 6. Ann Arbour Science.
36. Tower S.S. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J. Bone Joint Surg. Am. 2010, 92:2847-2851.
37. Black J. Systemic effects of biomaterials. Biomaterials 1984, 5:11-18.
38. Dillon C.T., et al. Permeability, cytotoxicity, and genotoxicity of Cr(III) complexes and some Cr(V) analogues in V79 Chinese hamster lung cells. Chem. Res. Toxicol. 2000, 13:742-748.
39. Champion J.A., et al. Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res. 2008, 25:1815-1821.
40. Yue H., et al. Particle size affects the cellular response in macrophages. Eur. J. Pharm. Sci. 2010, 41:650-657.
41. Colognato R., et al. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis 2008, 23:377-382.
42. Witmer C., et al. In vivo effects of chromium. Environ. Health Perspect. 1994, 102(Suppl. 3):169-176.
43. Messer R.L., et al. Effects of metallic ion toxicity on human gingival fibroblasts morphology. Biomaterials 1999, 20:1647-1657.
44. Alexander J., Aaseth J. Uptake of chromate in human red blood cells and isolated rat liver cells: the role of the anion carrier. Analyst 1995, 120:931-933.
45. Debetto P., et al. Uptake of chromate by rat thymocytes and role of glutathione in its cytoplasmic reduction. Xenobiotica 1988, 18:657-664.
46. Shi X., Dalal N.S. Generation of hydroxyl radical by chromate in biologically relevant systems: role of Cr(V) complexes versus tetraperoxochromate(V). Environ. Health Perspect. 1994, 102(Suppl. 3):231-236.
47. Kwon Y.M., et al. Dose-dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on macrophages in vitro. Biomed. Mater. 2009, 4:25018.
48. Catelas I., et al. TNF-α secretion and macrophage mortality induced by cobalt and chromium ions in vitro - qualitative analysis of apoptosis. Biomaterials 2003, 24:383-391.
49. Akbar M., et al. Effect of chromium and cobalt ions on primary human lymphocytes in vitro. J. Immunotoxicol. 2011, 8:140-149.
50. Papageorgiou I., et al. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 2007, 28:2946-2958.
51. Cheville N.F. Ultrastructural Pathology: An Introduction to Interpretation 1994, Blackwell.
52. Hartwig A. Current aspects in metal genotoxicity. Biometals 1995, 8:3-11.
53. IARC Surgical Implants and Other Foreign Bodies (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans) 1999, vol. 74. World Health Organization.
54. IARC Chromium and Chromium Compounds: Chromium[VI] (Group 1), Metallic Chromium and Chromium[III] Compounds (Group 3) (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans) 1997, vol. 49. World Health Organization.
55. Lloyd D.R., et al. Comparison of the formation of 8-hydroxy-2'-deoxyguanosine and single- and double-strand breaks in DNA mediated by Fenton reactions. Chem. Res. Toxicol. 1998, 11:420-427.
56. Baldwin E.L., et al. Cobalt enhances DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells. Biochemistry 2004, 43:728-735.
57. Witkiewicz-Kucharczyk A., Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol. Lett. 2006, 162:29-42.
58. Reynolds M.F., et al. Rapid DNA double-strand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers. Cancer Res. 2009, 69:1071-1079.
59. Zhitkovich A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol. 2005, 18:3-11.
60. Ladon D., et al. Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J. Arthroplasty 2004, 19:78-83.
61. Dunstan E., et al. Chromosomal aberrations in the peripheral blood of patients with metal-on-metal hip bearings. J. Bone Joint Surg. Am. 2008, 90A:517-522.
62. Visuri T., et al. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc. Inst. Mech. Eng. H 2006, 220:399-407.
63. Visuri T., et al. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin. Orthop. Relat. Res. 1996, S280-S289.
64. Yang M. A current global view of environmental and occupational cancers. J. Environ. Sci. Health C: Environ. Carcinog. Ecotoxicol. Rev. 2011, 29:223-249.
65. + T-cell lymphopenia. J. Bone Joint Surg. Br. 2009, 91:835-842.
66. Goodman S.B. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 2007, 28:5044-5048.
67. Hallab N.J., et al. Immune responses correlate with serum-metal in metal-on-metal hip arthroplasty. J. Arthroplasty 2004, 19:88-93.
68. Granchi D., et al. Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J. Bone Joint Surg. Br. 2003, 85-B:758-764.
69. Basketter D.A., et al. Nickel, cobalt and chromium in consumer products: a role in allergic contact dermatitis?. Contact Dermat. 1993, 28:15-25.
70. Hallab N.J., et al. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation. Mol. Cell. Biochem. 2001, 222:127-136.
71. Jacobs J.J., Hallab N.J. Loosening and osteolysis associated with metal-on-metal bearings: A local effect of metal hypersensitivity?. J. Bone Joint Surg. Am. 2006, 88:1171-1172.
72. Korovessis P., et al. Metallosis after contemporary metal-on-metal total hip arthroplasty. Five to nine-year follow-up. J. Bone Joint Surg. Am. 2006, 88:1183-1191.
73. Huber M., et al. Presence of corrosion products and hypersensitivity-associated reactions in periprosthetic tissue after aseptic loosening of total hip replacements with metal bearing surfaces. Acta Biomater. 2009, 5:172-180.
74. Thomas P., et al. Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy 2009, 64:1157-1165.
75. Mahendra G., et al. Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties. Acta Orthop. 2009, 80:653-659.
76. Wynn-Jones H., et al. Silent soft tissue pathology is common with a modern metal-on-metal hip arthroplasty. Acta Orthop. 2011, 82:301-307.
77. Bolland B.J., et al. High failure rates with a large-diameter hybrid metal-on-metal total hip replacement: clinical, radiological and retrieval analysis. J. Bone Joint Surg. Br. 2011, 93:608-615.
78. Glyn-Jones S., et al. Risk factors for inflammatory pseudotumour formation following hip resurfacing. J. Bone Joint Surg. Br. 2009, 91:1566-1574.
79. Andrews R.E., et al. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: Implications for skeletal health. Bone 2011, 49:717-723.
80. Madathil B.K., et al. Hypoxia-like effect of cobalt chromium alloy micro particles on fibroblasts in vitro. J. Orthop. Res. 2010, 28:1360-1367.
81. El-Yamani N., et al. Chromium-induced genotoxicity and interference in human lymphoblastoid cell (TK6) repair processes. J. Toxicol. Environ. Health A 2011, 74:1030-1039.
82. Papageorgiou I., et al. Genotoxic effects of particles of surgical cobalt chrome alloy on human cells of different age in vitro. Mutat. Res. 2007, 619:45-58.
83. Kwon Y.M., et al. Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J. Orthop. Res. 2010, 28:444-450.
84. Thyssen J.P., et al. The association between metal allergy, total hip arthroplasty, and revision. Acta Orthop. 2009, 80:646-652.
85. Park Y.S., et al. Early osteolysis following second-generation metal-on-metal hip replacement. J. Bone Joint Surg. Am. 2005, 87:1515-1521.